| Validated Xenograft Models |
| Subcutaneous | Breast | MCF-7(ER neg), MDA-MB-231, SK-BR-3, BT474, MX-1 |
|---|
| Prostate | DU-145, PC-3, LNCaP, 22RV1 |
|---|
| Colorectal | HT-29, HCT-116, DLD-1, SW620, LoVo, Colo-205, SW480, Colo-320DM |
|---|
| Lung | A549, NCI-H460, SK-MES-1, NCI-H226, Calu-6, H1975, H1703 |
|---|
| Glioblastoma | U87MG,U118 |
|---|
| Fibrosarcoma | HT-1080 |
|---|
| Pancreatic | Mia-Paca-2, Bx-PC-3, PANC-1, Capan-1, AsPc-1 |
|---|
| Kidney | 786-O, A498 |
|---|
| Liver | HepG2, SK-HEP-1, Hep3B, PLC/PRF/5, HUH-1, HUH-7 |
|---|
| Osteosarcoma | 143B, SJSA-1 |
|---|
| Melanoma | A375, SK-MEL-5, A2058 |
|---|
| Nasopharyngeal | CNE2 |
|---|
| Gastric | MGC803, BGC823, NCI-N87, YCC-2, YCC-16 |
|---|
| Ovarian | SK-OV-3, OVCAR-3 |
|---|
| Leukemia | K562, HL-60, MV-4-11 |
|---|
| Lymphoma | Namalwa, Daudi |
|---|
| Multiple myeloma | RPMI-8226 |
|---|
| Oral cancers | KB |
|---|
| Bladder | 5637 |
|---|
| Epidermoid Carcinoma | A431 |
|---|
| Orthotopic | Breast | BT474, MDA-MB-231 MCF-7(ER pos), MCF-7(her2+), MCF-7 (ER neg), MCF-7-218 (ERpos) |
|---|
| Prostate | LNCaP, DU-145 |
|---|
| Lung | A549, H1975,H460 |
|---|
| Glioblastoma | U87MG, LN-229 , U118 |
|---|
| Pancreatic | MiaPaCa-2, PANC-1 |
|---|
| Kidney | 786-O |
|---|
| Liver | HepG2,MHCC97H |
|---|
| Systemic Tumors | Myeloma | RPMI-8226, OPM-2, MM1S, NCI-H929, MM1R |
|---|
| Leukemia | HL60, MV-4-11, Molt-4, K562 |
|---|
| Lymphoma | Namalwa, Daudi |
|---|
| Syngeneic Models |
| Subcutaneous | Lung | LLC |
|---|
| Liver | H22 |
|---|
| Kidney | Renca |
|---|
| Colon | CT-26 |
|---|
| Metastatic | Melanoma | B16F10, B16BL6 |
|---|
| Systemic Tumors | Lung | LLC |
|---|
| Angiogenesis Models |
| Window Chamber | All | Any |
|---|
| Matrigel Plug Assay | Lung | A549 |
|---|
